Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1066

1.

Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines.

Li H, Zhou S, Li X, Wang D, Wang Y, Zhou C, Schmid-Bindert G.

Cancer Biother Radiopharm. 2013 Mar;28(2):115-23. doi: 10.1089/cbr.2012.1268. Epub 2012 Dec 27.

2.

The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis.

Cheng G, Kong D, Hou X, Liang B, He M, Liang N, Ma S, Liu X.

Cancer Biother Radiopharm. 2013 Mar;28(2):153-9. doi: 10.1089/cbr.2012.1297. Epub 2012 Dec 26.

3.

Different cell cycle modulation by celecoxib at different concentrations.

Kim YM, Pyo H.

Cancer Biother Radiopharm. 2013 Mar;28(2):138-45. doi: 10.1089/cbr.2012.1264. Epub 2012 Dec 26.

4.

Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.

Chen S, Xiong G, Wu S, Mo J.

Cancer Biother Radiopharm. 2013 Mar;28(2):169-76. doi: 10.1089/cbr.2012.1266. Epub 2012 Dec 26.

PMID:
23268706
5.

Overexpression of Smac promotes Cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cells.

Qin S, Yang C, Wang X, Xu C, Li S, Zhang B, Ren H.

Cancer Biother Radiopharm. 2013 Mar;28(2):177-82. doi: 10.1089/cbr.2012.1261. Epub 2012 Dec 19.

PMID:
23252748
6.

Comparison of 211At-PRIT and 211At-RIT of ovarian microtumors in a nude mouse model.

Frost SH, Bäck T, Chouin N, Hultborn R, Jacobsson L, Elgqvist J, Jensen H, Albertsson P, Lindegren S.

Cancer Biother Radiopharm. 2013 Mar;28(2):108-14. doi: 10.1089/cbr.2012.1281. Epub 2012 Dec 11.

PMID:
23230896
7.

Cisplatin-induced neurotoxicity in vivo can be alleviated by riboflavin under photoillumination.

Hassan I, Chibber S, Khan AA, Naseem I.

Cancer Biother Radiopharm. 2013 Mar;28(2):160-8. doi: 10.1089/cbr.2012.1312. Epub 2012 Dec 7.

PMID:
23215961
8.

Patient-specific whole-body attenuation correction maps from a CT system for conjugate-view-based activity quantification: method development and evaluation.

Gleisner KS, Ljungberg M.

Cancer Biother Radiopharm. 2012 Dec;27(10):652-64. doi: 10.1089/cbr.2011.1082.

PMID:
23210927
9.

Ether à go-go 1 silencing in combination with TRAIL overexpression has synergistic antitumor effects on osteosarcoma.

Wu J, Zeng T, Wu X, Gao Q, Zhai W, Ding Z.

Cancer Biother Radiopharm. 2013 Feb;28(1):65-70. doi: 10.1089/cbr.2012.1283. Epub 2012 Nov 12.

PMID:
23145797
10.

Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.

Wei L, Song XR, Sun JJ, Wang XW, Xie L, Lv LY.

Cancer Biother Radiopharm. 2012 Dec;27(10):672-7. doi: 10.1089/cbr.2012.1241. Epub 2012 Nov 9.

11.

Inhibition of lung adenocarcinoma transfected with interleukin 28A recombinant adenovirus (Ad-mIFN-λ2) in vivo.

Yan Y, Zhang J, Liu Y, Zhu T, Yuan L, Ge Y, Ding H, Bu X.

Cancer Biother Radiopharm. 2013 Mar;28(2):124-30. doi: 10.1089/cbr.2012.1247. Epub 2012 Nov 7.

PMID:
23134221
12.

Usefulness of dual-time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancer.

Filippi L, D'Arienzo M, Scopinaro F, Salvatori R, Bagni O.

Cancer Biother Radiopharm. 2013 Feb;28(1):29-33. doi: 10.1089/cbr.2012.1179. Epub 2012 Nov 7.

PMID:
23134220
13.

Expression of serum response factor in gastric carcinoma and its molecular mechanisms involved in the regulation of the invasion and migration of SGC-7901 cells.

Zhao M, Xu H, He X, Hua H, Luo Y, Zuo L.

Cancer Biother Radiopharm. 2013 Mar;28(2):146-52. doi: 10.1089/cbr.2012.1265. Epub 2012 Nov 7.

PMID:
23134219
14.

MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.

Wang YY, Ren T, Cai YY, He XY.

Cancer Biother Radiopharm. 2013 Mar;28(2):131-7. doi: 10.1089/cbr.2012.1307. Epub 2012 Nov 7.

PMID:
23134218
15.

Bax is essential for death receptor-mediated apoptosis in human colon cancer cells.

Zhu S, Li T, Tan J, Yan X, Zhang D, Zheng C, Chen Y, Xiang Z, Cui H.

Cancer Biother Radiopharm. 2012 Nov;27(9):577-81. doi: 10.1089/cbr.2012.1256.

PMID:
23113596
16.

Compton scattering by internal shields based on melanin-containing mushrooms provides protection of gastrointestinal tract from ionizing radiation.

Revskaya E, Chu P, Howell RC, Schweitzer AD, Bryan RA, Harris M, Gerfen G, Jiang Z, Jandl T, Kim K, Ting LM, Sellers RS, Dadachova E, Casadevall A.

Cancer Biother Radiopharm. 2012 Nov;27(9):570-6. doi: 10.1089/cbr.2012.1318.

17.

Phase I-II study of radiopeptide 177Lu-octreotate in combination with capecitabine and temozolomide in advanced low-grade neuroendocrine tumors.

Claringbold PG, Price RA, Turner JH.

Cancer Biother Radiopharm. 2012 Nov;27(9):561-9. doi: 10.1089/cbr.2012.1276. Epub 2012 Oct 18.

PMID:
23078020
18.

Radiopharmaceuticals for bone metastasis therapy and beyond: a voyage from the past to the present and a look to the future.

Ferreira S, Dormehl I, Botelho MF.

Cancer Biother Radiopharm. 2012 Nov;27(9):535-51. doi: 10.1089/cbr.2012.1258. Epub 2012 Oct 17. Review.

PMID:
23075374
19.

Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy.

Guérard F, Gestin JF, Brechbiel MW.

Cancer Biother Radiopharm. 2013 Feb;28(1):1-20. doi: 10.1089/cbr.2012.1292. Epub 2012 Oct 17. Review.

20.

Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.

Hsu CW, Chang YJ, Chang CH, Chen LC, Lan KL, Ting G, Lee TW.

Cancer Biother Radiopharm. 2012 Oct;27(8):481-9. doi: 10.1089/cbr.2011.1158.

PMID:
23067100

Supplemental Content

Loading ...
Support Center